Trial of calcium to prevent preeclampsia

New England Journal of Medicine

Volumn 337, Issue 2, 1997, Pages 69-76

  Levine, Richard J ^a   Hauth, John C ^b   Curet, Luis B ^c   Sibai, Baha M ^d   Catalano, Patrick M ^e   Morris, Cynthia D ^f   DerSimonian, Rebecca ^a   Esterlitz, Joy R ^g   Raymond, Elizabeth G ^a,h   Bild, Diane E ⁱ   Clemens, John D ^a   Cutler, Jeffrey A ⁱ   Ewell, Marian G ^g   Friedman, Steven A ^d   Goldenberg, Robert L ^b   Jacobson, Sig Linda ^f   Joffe, Gary M ^c   Klebanoff, Mark A ^a   Petrulis, Alice S ^e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^e METROHEALTH MEDICAL CENTER   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g EMMES CORPORATION   (United States)

^h FAMILY HEALTH INTERNATIONAL   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CALCIUM INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PREECLAMPSIA; PRENATAL CARE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; CALCIUM; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PROTEINURIA; UNITED STATES; URINARY CALCULI;

EID: 0030803395     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199707103370201     Document Type: Article

References (36)

1. Hypertensive disorders in pregnancy. In: Cunningham FG, MacDonald PC, Gant NF. Williams obstetrics. 18th ed. Norwalk, Conn.: Appleton & Lange, 1989:653-94.
2. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163: 1689-712.
3. Theobald GW. Effect of calcium and vitamins A and D on incidence of pregnancy toxaemia. Lancet 1937;1:1397-9.
4. Nutrition of expectant and nursing mothers: interim report of the People's League of Health. Lancet 1942;2:10-2.
5. Chaudhuri SK. Calcium deficiency and toxaemia of pregnancy. J Obstet Gynaecol India 1969;19:313-6.
6. Montanaro D, Boscutti G, Antonucci F, et al. Prevention of pregnancy-induced hypertension (P.I.H.) and preeclampsia (P.E.) by oral calcium supplementation: preliminary results. Miner Metab Res Italy 1986;7:121-4.
7. Marya RK, Rathee S, Manrow M. Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecol Obstet Invest 1987;24: 38-42.
8. Lopez-Jaramillo P, Narvaez M, Weigel RM, Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 1989;96:648-55.
9. Lopez-Jaramillo P, Narvaez M, Felix C, Lopez A. Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet 1990; 335:293.
10. Villar J, Repke JT. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol 1990;163:1124-31.
11. Belizán JM, Villar J, Gonzalez L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991;325:1399-405.
12. 3 in an antenatal protocol. Int J Gynaecol Obstet 1994;47:115-20.
13. Sanchez-Ramos L, Briones DK, Kaunitz AM, Delvalle GO, Gaudier FL, Walker CD. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet Gynecol 1994; 84:349-53.
14. Cong K, Chi S, Liu G. Calcium and pregnancy induced hypertension. Chung Hua Fu Chan Ko Tsa Chih 1993;28:657-9. (In Chinese.)
15. Suzuki Y, Itoh Y, Hayashi Y, et al. Calcium supplementation to prevent gestational hypertension. In: Abstract book: 10th World Congress: International Society for the Study of Hypertension in Pregnancy, Seattle, August 4-8, 1996:152. abstract.
16. Duley L. Prevention and treatment of pre-eclampsia. Oxford Database of Perinatal Trials Newsletter. February 1991:2-4.
17. Levine RJ, Raymond E, DerSimonian R, Clemens JD. Preeclampsia prevention with calcium supplementation. Clin Appl Nutr 1992;2:30-8.
18. Carroli G, Duley L, Belizan JM, Villar J. Calcium supplementation during pregnancy: a systematic review of randomised controlled trials. Br J Obstet Gynaecol 1994;101:753-8.
19. DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med 1996;15:1237-48.
20. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996;275:1113-7.
21. Levine RJ, Esterlitz JR, Raymond EG, et al. Trial of Calcium for Pre-eclampsia Prevention (CPEP): rationale, design, and methods. Control Clin Trials 1996;17:442-69.
22. Levine RJ, DerSimonian R. Effects of calcium supplementation on pregnancy-induced hypertension. JAMA 1996;276:1387.
23. Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976;126:555-64.
24. Trudeau DL, Freier EF. Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). Clin Chem 1967;13:101-14.
25. Hoffman RJ, Feld RD. A modified procedure for creatinine (CRT) which eliminates bilirubin (BILT) interference on the Hitachi 737. Clin Chem 1988;34:1313. abstract.
26. Swanson AF, Swartzentruber M, Nolen PA, Crawford K, Sine HE. Multicenter evaluation of the Boehringer Mannheim compensated, rate-blanked creatinine/Jaffe application on BM/Hitachi systems. In: Advances in clinical diagnostics. Indianapolis: Boehringer Mannheim, 1993:3-11.
27. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York: Van Nostrand Reinhold, 1982:340-55.
28. Diggle PJ, Liang K-Y, Zeger SL. Analysis of longitudinal data. Oxford, England: Oxford University Press, 1994.
29. Kalbfleisch ID, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
30. Heaney RP, Skillman TG. Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab 1971;33:661-70.
31. Maikranz P, Holley JL, Parks JH, Lindheimer MD, Nakagawa Y, Coe FL. Gestational hvpercalciuria causes pathological urine calcium oxalate supersaturations. Kidney Int 1989;36:108-13.
32. Calcium and hypocalcemia. In: Klaus MH, Fanaroff AA, eds. Care of the high-risk neonate. 3rd ed. Philadelphia: W.B. Saunders, 1986:227-31.
33. Villar J, Repke J, Belizan JM, Pareja G. Calcium supplementation reduces blood pressure during pregnancy: results of a randomized controlled clinical trial. Obstet Gynecol 1987;70:317-22.
34. Wachter KW. Disturbed by meta-analysis? Science 1988;241:1407-8.
35. Baxter GF, Sumeray MS, Walker JM. Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet 1996; 348:1424-6.
36. Borzak S, Ridker PM. Discordance between meta-analyses and large-scale randomized, controlled trials: examples from the management of acute myocardial infarction. Ann Intern Med 1995;123:873-7.